Furthermore, GPER-1 expression seems to be a favorable factor for relapse-free survival, but only in patients that did not receive tamoxifen; consequently, loss of GPER-1 improves the prognosis in patients treated with tamoxifen indicating that GPER-1 might be related to tamoxifen resistance in breast cancer (25). The gene discussed is GPER1; the disease is breast cancer.